Nancy Stuart, Chief Operating Officer at CONCERT PHARMACEUTICALS, INC. (CNCE), sold 62,836 shares at $17.56 ($1.1M) on 2018-07-09, disclosed to the SEC on 2018-07-11.
Open-market sale of $1.1M CNCE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.56 | 5,291 | $93K | 8.3% |
| 2 | $17.56 | 5,291 | $93K | 8.3% |
| 3 | $17.94 | 26,127 | $469K | 41.7% |
| 4 | $17.94 | 26,127 | $469K | 41.7% |
| Total | $17.88 avg | 62,836 | $1.1M | 100% |
| Filing → |
| CNCE | SELL | 2023-01-09 | $21K | — | Filing → |
| CNCE | SELL | 2022-02-16 | $19K | — | Filing → |
| CNCE | SELL | 2022-01-07 | $9K | — | Filing → |